BIOMAT Database Logo BIOMAT Database Logo

[Analysis of p53 expression and DNA ploidy pattern in colorectal cancer]. 1993

T Nakamura, and S Hishiki, and S Baba
Dept. of Surgery, Inasa Red Cross Hospital.

An immunohistological staining for p53 conducted in 114 cases of colorectal cancer. The background risk factors such as pathological and DNA ploidy patterns were analized in all cases. p53 was found in 50.0% (57/114). There was a slight increase in p53 positive cases in the advanced cancers, but it was not statistically significant. Five-year survival rates of Dukes B and C were 42.2% for p53-positive cases and 67.2% for p53-negative cases. There was a statistical difference (p < 0.05), but none in the Dukes A group. Study of p53 in combination with DNA ploidy patterns revealed an even greater disparity in survival rates (p < 0.01) between p53-positive aneuploid cases and p53-negative diploid cases. These results indicate that the staining of p53 in conjunction DNA ploidy patterns may be a useful indicator of prognosis in the cases of colorectal cancer.

UI MeSH Term Description Entries
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D011003 Ploidies The degree of replication of the chromosome set in the karyotype. Ploidy
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015179 Colorectal Neoplasms Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI. Colorectal Cancer,Colorectal Carcinoma,Colorectal Tumors,Neoplasms, Colorectal,Cancer, Colorectal,Cancers, Colorectal,Carcinoma, Colorectal,Carcinomas, Colorectal,Colorectal Cancers,Colorectal Carcinomas,Colorectal Neoplasm,Colorectal Tumor,Neoplasm, Colorectal,Tumor, Colorectal,Tumors, Colorectal
D015870 Gene Expression The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION. Expression, Gene,Expressions, Gene,Gene Expressions
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival
D016158 Genes, p53 Tumor suppressor genes located on the short arm of human chromosome 17 and coding for the phosphoprotein p53. Genes, TP53,TP53 Genes,p53 Genes,Gene, TP53,Gene, p53,TP53 Gene,p53 Gene

Related Publications

T Nakamura, and S Hishiki, and S Baba
[Analysis of p53 expression and DNA ploidy pattern in esophageal cancer].
June 1995, Gan to kagaku ryoho. Cancer & chemotherapy,
T Nakamura, and S Hishiki, and S Baba
p53 expression and DNA ploidy pattern in Egyptian colorectal carcinoma.
January 2002, Hepato-gastroenterology,
T Nakamura, and S Hishiki, and S Baba
p53 expression in colorectal cancer: relation to tumor type, DNA ploidy pattern and short-term survival.
May 1996, American journal of clinical pathology,
T Nakamura, and S Hishiki, and S Baba
[DNA ploidy pattern and p53 overexpression in gastric cancer].
June 1995, Gan to kagaku ryoho. Cancer & chemotherapy,
T Nakamura, and S Hishiki, and S Baba
DNA ploidy pattern and tumor suppressor gene p53 expression in gallbladder carcinoma.
July 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
T Nakamura, and S Hishiki, and S Baba
p53 mutations and DNA ploidy in colorectal adenocarcinomas.
January 1998, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology,
T Nakamura, and S Hishiki, and S Baba
[p21ras expression, DNA ploidy and prognosis in colorectal cancer].
August 1994, Zhonghua wai ke za zhi [Chinese journal of surgery],
T Nakamura, and S Hishiki, and S Baba
Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
January 2004, Hepato-gastroenterology,
T Nakamura, and S Hishiki, and S Baba
Prognostic significance of p53 expression in relation to DNA ploidy in colorectal adenocarcinoma.
January 1993, Virchows Archiv. A, Pathological anatomy and histopathology,
T Nakamura, and S Hishiki, and S Baba
[An immunohistochemical study of the relationship between p53 expression and the DNA ploidy pattern using image cytometry in colorectal carcinoma].
June 1995, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!